We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Advances in Fragment-based Drug Discovery

Article   May 21, 2018 | by Laura Elizabeth Mason, Science Writer, Technology Networks

 
Advances in Fragment-based Drug Discovery
 
 
 

RELATED ARTICLES

Anti-inflammatory Drugs Resurrected To Fight Chronic Pain

Article

Failed drugs often are left on the shelf to gather dust. But sometimes, drugs can be dusted down and repurposed. That’s exactly the route that Katexco Pharmaceuticals has taken with its new immune system-targeting compounds, part of a new life sciences company that aims to target everything from multiple sclerosis to chronic pain.

READ MORE

Angiogenesis in Cancer

Article

In this article we take a look at the relationship between angiogenesis and cancer, highlight the role of p38α in the regulation of angiogenesis, explore the existence of non-angiogenic tumors, and discuss the ways to therapeutically target angiogenesis.

READ MORE

Therapeutic Gene Editing for Sickle Cell Disease

Article

Sickle cell disease is the most common inherited blood disorder in the US, affecting > 70,000 Americans. Christopher Vakulskas, Senior Staff Scientist, Integrated DNA Technologies discusses efforts to develop a sickle cell disease therapy using CRISPR gene editing.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE